Target
Pteridine reductase 1
Ligand
BDBM50303517
Substrate
n/a
Meas. Tech.
ChEMBL_596055 (CHEMBL1037349)
Ki
27000±n/a nM
Citation
 Tulloch, LBMartini, VPIulek, JHuggan, JKLee, JHGibson, CLSmith, TKSuckling, CJHunter, WN Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases. J Med Chem 53:221-9 (2010) [PubMed]  Article 
Target
Name:
Pteridine reductase 1
Synonyms:
HMTXR | PTR1 | PTR1_LEIMA
Type:
PROTEIN
Mol. Mass.:
30459.34
Organism:
Leishmania major
Description:
ChEMBL_1470027
Residue:
288
Sequence:
MTAPTVPVALVTGAAKRLGRSIAEGLHAEGYAVCLHYHRSAAEANALSATLNARRPNSAITVQADLSNVATAPVSGADGSAPVTLFTRCAELVAACYTHWGRCDVLVNNASSFYPTPLLRNDEDGHEPCVGDREAMETATADLFGSNAIAPYFLIKAFAHRFAGTPAKHRGTNYSIINMVDAMTNQPLLGYTIYTMAKGALEGLTRSAALELAPLQIRVNGVGPGLSVLVDDMPPAVWEGHRSKVPLYQRDSSAAEVSDVVIFLCSSKAKYITGTCVKVDGGYSLTRA
  
Inhibitor
Name:
BDBM50303517
Synonyms:
2,4-diamino-6-(p-tolylthio)pyrimidin-1-ium | 6-[(4-methylphenyl)sulfanyl]pyrimidine-2,4-diamine | CHEMBL578789
Type:
Small organic molecule
Emp. Form.:
C11H12N4S
Mol. Mass.:
232.305
SMILES:
Cc1ccc(Sc2cc(N)nc(N)n2)cc1
Structure:
Search PDB for entries with ligand similarity: